Olympus Agree on Transfer of Evident to Bain Capital ~Evident to accelerate its growth and innovation~

Tokyo, August 29, 2022 – Olympus Corporation (“Olympus”) and EVIDENT Co., Ltd. (“Evident”), a wholly-owned subsidiary of Olympus announced today that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to Bain Capital on January... Read more

Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software

New nanoElute 2 features nano-LC advances, supports automated single cell sample preparation from label-free ProteoCHIP on CellenONE platform MetaboScape ® 2023 advances fluxomics applications and ion mobility offset mass aligned (‘MOMA’) events for high-throughput 4D-Metabolomics Advances in MALDI HiPLEX-IHC™ workflows, and in PaSER™ on-the-fly intelligent acquisition software for 4D-Metaproteomics MAASTRICHT, Netherlands–(BUSINESS WIRE)– At the International... Read more

[Delayed] Annual Securities Report for Fiscal Year Ended March 31, 2022

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Thermo Fisher Scientific to Sponsor Nation’s Premier Middle School STEM Competition

The Society for Science names Thermo Fisher the new title sponsor for its annual STEM competition, expanding opportunity for thousands of middle school students across the U.S. WALTHAM, Mass., and WASHINGTON, D.C., August 25, 2022 – The Society for Science (Society) and Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced... Read more

Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations

Novel NMR Probe Technologies, GHz-class NMR and Dynamics Software Enable New Research, and Advance Functional Structural Biology and Drug Discovery BOSTON–(BUSINESS WIRE)– At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes. The new technology... Read more